ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,110, issued on June 17, was assigned to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Monoclonal antibodies against endotrophin and the use thereof" was invented by Ningyan Zhang (Houston), Dawei Bu (Dallas), Zhiqiang An (Houston), Hui Deng (Houston) and Philipp E. Scherer (Dallas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the present invention relate to methods and reagents for increasing chemosensitivity to platinum-based chemotherapy. In one aspect, a method of increasing chemosensitivity to platinum-based chemotherapy is provided, comprising administering to a patient in need thereof an effective amount ...